Sciatica
3
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
1
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Mission TherapeuticsUK - Cambridge
1 programPain Relief by Platelet-rich Plasma (PRP) TreatmentN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
TevaCEP-37247
BiogenBG00010
Mission TherapeuticsPain Relief by Platelet-rich Plasma (PRP) Treatment
Clinical Trials (3)
Total enrollment: 179 patients across 3 trials
Study to Evaluate the Safety and Efficacy of Placulumab (CEP-37247) Administered by the Transforaminal Epidural Route for the Treatment of Patients With Lumbosacral Radicular Pain Associated With Disk Herniation
Start: Jan 2011Est. completion: Apr 201398 patients
Phase 1/2Completed
Study of the Safety, Tolerability, Pharmacokinetics and Safety of BG00010 (Neublastin) in Subjects With Sciatica.
Start: Jul 2011Est. completion: Sep 201256 patients
Phase 1Completed
Pain Relief by Platelet-rich Plasma (PRP) Treatment
Start: Dec 2012Est. completion: Dec 201425 patients
N/AUnknown
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space